These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
673 related articles for article (PubMed ID: 28523761)
1. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients. Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761 [TBL] [Abstract][Full Text] [Related]
2. Contradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV. El Sobky SA; El-Ekiaby NM; Mekky RY; Elemam NM; Mohey Eldin MA; El-Sayed M; Esmat G; Abdelaziz AI Immunol Lett; 2016 Jan; 169():52-60. PubMed ID: 26518141 [TBL] [Abstract][Full Text] [Related]
3. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Heinemann A; Zhao F; Pechlivanis S; Eberle J; Steinle A; Diederichs S; Schadendorf D; Paschen A Cancer Res; 2012 Jan; 72(2):460-71. PubMed ID: 22102694 [TBL] [Abstract][Full Text] [Related]
4. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus. Hervier B; Ribon M; Tarantino N; Mussard J; Breckler M; Vieillard V; Amoura Z; Steinle A; Klein R; Kötter I; Decker P Front Immunol; 2021; 12():633658. PubMed ID: 34012432 [TBL] [Abstract][Full Text] [Related]
5. NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker. Guo G; Wang H; Shi X; Ye L; Wu K; Lin K; Ye S; Li B; Zhang H; Lin Q; Ye S; Xue X; Chen C J Transl Med; 2018 Dec; 16(1):370. PubMed ID: 30577810 [TBL] [Abstract][Full Text] [Related]
6. Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models. Elemam NM; Mekky RY; El-Ekiaby NM; El Sobky SA; El Din MA; Esmat G; Abdelaziz AI Hum Immunol; 2015 Sep; 76(9):687-94. PubMed ID: 26429314 [TBL] [Abstract][Full Text] [Related]
7. Targeting E2F1 and c-Myc expression by microRNA-17-5p represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric systemic lupus erythematosus patients. Sarhan RA; Aboelenein HR; Sourour SK; Fawzy IO; Salah S; Abdelaziz AI Discov Med; 2015 Jun; 19(107):419-25. PubMed ID: 26175399 [TBL] [Abstract][Full Text] [Related]
8. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus. Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119 [TBL] [Abstract][Full Text] [Related]
9. Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Hai-yan W; Yang L; Mei-hong C; Hui Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):185-8. PubMed ID: 21529448 [TBL] [Abstract][Full Text] [Related]
10. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE. Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145 [TBL] [Abstract][Full Text] [Related]
11. Altered NK-cell compartment and dysfunctional NKG2D/NKG2D-ligand axis in patients with ataxia-telangiectasia. Desimio MG; Finocchi A; Di Matteo G; Di Cesare S; Giancotta C; Conti F; Chessa L; Piane M; Montin D; Dellepiane M; Rossi P; Cancrini C; Doria M Clin Immunol; 2021 Sep; 230():108802. PubMed ID: 34298181 [TBL] [Abstract][Full Text] [Related]
12. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma. Abdelrahman MM; Fawzy IO; Bassiouni AA; Gomaa AI; Esmat G; Waked I; Abdelaziz AI Hum Immunol; 2016 Aug; 77(8):667-673. PubMed ID: 27262453 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus. Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980 [TBL] [Abstract][Full Text] [Related]
15. The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer. Gharagozloo M; Kalantari H; Rezaei A; Maracy MR; Salehi M; Bahador A; Hassannejad N; Narimani M; Sanei MH; Bayat B; Ghazanfari H Bratisl Lek Listy; 2015; 116(5):296-301. PubMed ID: 25924638 [TBL] [Abstract][Full Text] [Related]
16. miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA. Yuan S; Tang C; Chen D; Li F; Huang M; Ye J; He Z; Li W; Chen Y; Lin X; Wang X; Cai X J Immunol Res; 2019; 2019():9827574. PubMed ID: 31886314 [TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9. Sun H; Guo F; Xu L J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179 [TBL] [Abstract][Full Text] [Related]
19. The role of miR-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus. Luo X; Zhang L; Li M; Zhang W; Leng X; Zhang F; Zhao Y; Zeng X Clin Exp Rheumatol; 2013; 31(2):263-71. PubMed ID: 23305626 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of survivin expression and regulating miRNAs of survivin expression in peripheral blood mononuclear cells in systemic lupus erythematous patients. Bolouri N; Mansouri R; Farhadi E; Soltani S; Akhtari M; Madreseh E; Faezi ST; Jafarinejad-Farsangi S; Jamshidi A; Mahmoudi M Lupus; 2024 Oct; 33(11):1203-1211. PubMed ID: 39162618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]